TrialJournal for immunotherapy of cancer2018

Randomized phase II trial of autologous dendritic cell vaccines versus autologous tumor cell vaccines in metastatic melanoma: 5-year follow up and additional analyses.

Robert O Dillman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.